Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Finished Goods (2019 - 2025)

Ptc Therapeutics (PTCT) has 7 years of Finished Goods data on record, last reported at $21.7 million in Q4 2025.

  • For Q4 2025, Finished Goods rose 156.75% year-over-year to $21.7 million; the TTM value through Dec 2025 reached $21.7 million, up 156.75%, while the annual FY2025 figure was $21.7 million, 156.75% up from the prior year.
  • Finished Goods reached $21.7 million in Q4 2025 per PTCT's latest filing, up from $8.6 million in the prior quarter.
  • Across five years, Finished Goods topped out at $21.7 million in Q4 2025 and bottomed at $5.7 million in Q1 2022.
  • Average Finished Goods over 5 years is $8.3 million, with a median of $7.0 million recorded in 2021.
  • Peak YoY movement for Finished Goods: tumbled 38.3% in 2021, then skyrocketed 156.75% in 2025.
  • A 5-year view of Finished Goods shows it stood at $6.7 million in 2021, then dropped by 0.91% to $6.7 million in 2022, then skyrocketed by 74.79% to $11.6 million in 2023, then fell by 27.45% to $8.4 million in 2024, then surged by 156.75% to $21.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $21.7 million in Q4 2025, $8.6 million in Q3 2025, and $7.5 million in Q2 2025.